Braingaze Raises 1.5 Million to Develop Cognitive Health Solutions

Braingaze meets its funding aspirations. The spin off of the University of Barcelona (UB) specialized in digital cognitive health has closed an investment round in which it has raised 1.5 million euros. The round was led by Ryse Asset Management along with Orbit Startups and Artesian .

With this money, the Catalan company Braingaze wants to accelerate the clinical and business development of the therapeutic and diagnostic solutions in its portfolio to treat neurodegenerative diseases and cognitive disorders such as Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer’s or spectrum disorder. autistic​

Braingaze bases its business model on patented biomarkers of microeye movements, casual video games and deep learning algorithms in artificial intelligence (AI).

If you want to find more details about Braingaze and read the most important financial news of the day, download for free our companion app Born2Invest. Don;t waste your time scrolling the internet, our team of seasoned writers will do that for you so you can stay on top of the market.

Braingaze culminates twenty years of research by commercializing patented technology

This company’s solutions in the field of ADHD diagnosis have been used in medical centers in Madrid and Barcelona. Among Braingaze portfolio, the video game BGaze Therapy stands out, whose use as a therapeutic tool in clinics yields significant results among patients suffering from cognitive disorders such as the one mentioned.

Braingaze culminates two decades of research at the UB on cognitive attention brain circuits connected to the visual sensory system. Currently, this company has offices in Barcelona and London .

Ryse Asset Management is a manager specialized in the health and technology sector created in 2015 and based in the United Kingdom. In all her years of activity, she has worked with DigitalHealth.London, the most important health technology accelerator in Europe, Novartis or Medtronic .

Orbit Startups is a manager specialized in scaling innovative start-ups in emerging markets in Southeast and South Asia, the Middle East, Africa and America. Among its investment portfolio stands out VideoVerse, technological partner of the Olympic Games and the Premiere League , Elsa Speak, also beneficiary of investments from Google Gradient, or MarketForce, Africa’s main retail distribution system.

__

(Featured image by National Cancer Institute via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us